Abstract
Background
Despite tremendous advancements in cancer treatment delivery, we are still far from achieving successful cancer prognosis and cure. The use of new nanocarriers for site-specific delivery of anticancer medicines with lower toxicity has shown promise. However, the successful translation of these works into products remains a challenge. Hence, a thorough examination of the various nanocarrier systems is required, with particular emphasis on the more recent approaches.
Area Covered
The review discusses how nanocarrier designs have evolved with each generation based on EPR, overexpressed receptors, stimuli-responsive systems, intracellular and extracellular targeting, immunotherapy, and the recent multifunctional theranostic approach, as well as their potential and limitations. The clinical translations of these systems, as well as the issues that have arisen, have been examined, along with potential future opportunities. Newer immunosystems and multifunctional theranostic methods have received special attention.
Expert Opinion
It has been observed that nanocarrier systems have evolved in three major generations. Despite all of the efforts, clinical success is limited to the first generation of EPR-based passive targeting. Active targeting is mostly limited to the preclinical stage. Tumor heterogeneity and poor delivery to the location remain a key worry and roadblock. Hence, the newer generation nanocarriers need a more multifunctional approach, combining active targeting with immunotherapy and diagnostic contrast agent delivery. Newer theranostic designs with combined effects of chemotherapy, immunotherapy, and other therapies such as photodynamic, photothermal, and photoacoustic need to be worked on. Besides, there is a need of finding new cancer markers, toxicity studies, and scale-up approaches to these nanosystems.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Accardo A, Aloj L, Aurilio M, Morelli G, Tesauro D (2014) Receptor binding peptides for target-selective delivery of nanoparticles encapsulated drugs. Int J Nanomed 9:1537–1557. https://doi.org/10.2147/IJN.S53593
Afkham A, Aghebati-Maleki L, Siahmansouri H, Sadreddini S, Ahmadi MM et al (2018) Chitosan (CMD)-mediated co-delivery of SN38 and Snail-specific siRNA as a useful anticancer approach against prostate cancer. Pharmacol Rep 70(3):418–425. https://doi.org/10.1016/j.pharep.2017.11.005
Agrahari V, Agrahari V (2018) Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities. Drug Discov Today 23(5):974–991. https://doi.org/10.1016/j.drudis.2018.01.047
Ahn J, Sei YJ, Jeon NL, Kim YT (2017) Tumor microenvironment on a chip: the progress and future perspective. Bioengineering (basel) 4(3):64. https://doi.org/10.3390/bioengineering4030064
Akashi Y, Oda T, Ohara Y, Miyamoto R, Kurokawa T et al (2014) Anticancer effects of gemcitabine are enhanced by co-administered iRGD peptide in murine pancreatic cancer models that overexpressed neuropilin-1. Br J Cancer 110(6):1481–1487. https://doi.org/10.1038/bjc.2014.49
Akhtar MJ, Ahamed M, Alhadlaqa HA, Alrokayan SA, Kumar S (2014) Targeted anticancer therapy: Overexpressed receptors and nanotechnology. Clin Chim Acta 436:78–92. https://doi.org/10.1016/j.cca.2014.05.004
Alsuraifi A, Curtis A, Lamprou DA, Hoskins C (2018) Stimuli responsive polymeric systems for cancer therapy. Pharmaceutics 10(3):E136. https://doi.org/10.3390/pharmaceutics10030136
Aluri R, Jayakannan M (2017) Development of L-tyrosine-based enzyme-responsive amphiphilic poly(ester-urethane) nanocarriers for ultiple drug delivery to cancer cells. Biomacromol 18:189–200. https://doi.org/10.1021/acs.biomac.6b01476
Amreddy N, Babu A, Panneerselvam J, Srivastava A, Muralidharan R et al (2018) Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment. Nanomedicine 14(2):373–384. https://doi.org/10.1016/j.nano.2017.11.010
Ayatollahia S, Salmasi Z, Hashemi M, Askarian S, Oskueee RK et al (2017) Aptamer-targeted delivery of Bcl-xL shRNA using alkyl modified PAMAM dendrimers into lung cancer cells. Int J Biochem Cell Biol 92:210–217. https://doi.org/10.1016/j.biocel.2017.10.005
Baghirov H, Snipstad S, Sulheim E, Berg S, Hansen R et al (2018) Ultrasound-mediated delivery and distribution of polymeric nanoparticles in the normal brain parenchyma of a metastatic brain tumor mode. PLoS ONE 13(1):e0191102. https://doi.org/10.1371/journal.pone.0191102
Bai L, Liu Y, Guo K, Zhang K, Liu Q et al (2019) Ultrasound facilitates naturally equipped exosomes derived from macrophages and blood serum for orthotopic glioma treatment. ACS Appl Mater Interfaces 11:14576–14587. https://doi.org/10.1021/acsami.9b00893
Bashari O, Redko B, Cohen A, Luboshits G, Gellerman G et al (2017) Discovery of peptide drug carrier candidates for targeted multi-drug delivery into prostate cancer cells. Cancer Lett 408:164–173. https://doi.org/10.1016/j.canlet.2017.08.040
Battistella C, Klok H (2017) Controlling and monitoring intracellular delivery of anticancer polymer nanomedicines. Macromol Biosci 17(10):1700022. https://doi.org/10.1002/mabi.201700022
Battogtokh G, Cho YB, Lee JY, Lee HS, Kang HC (2018) Mitochondrial-targeting anticancer agent conjugates and nanocarrier systems for cancer treatment. Front Pharmacol 9:922. https://doi.org/10.3389/fphar.2018.00922
Bayraktar R, Pichler M, Kanlikilicer P, Ivan C, Bayraktar E et al (2017) MicroRNA 603 acts as a tumor suppressor and inhibits triple negative breast cancer tumorigenesis by targeting elongation factor 2 kinase. Oncotarget 8(7):11641–11658. https://doi.org/10.18632/oncotarget.14264
Bazak R, Houri M, El Achy S, Kamel S, Refaat T et al (2015) Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol 141(15):769–784. https://doi.org/10.1007/s00432-0141767-3
Bennie LA, McCarthy HO, Coulter JA (2018) Enhanced nanoparticle delivery exploiting tumor-responsive formulations. Cancer Nanotechnol 9(1):1–10. https://doi.org/10.1186/s12645-018-0044-6
Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3(6):401–410. https://doi.org/10.1038/nrc1093
Berguig GY, Convertine AJ, Frayo S, Kern HB, Procko E et al (2015) Intracellular delivery system for antibody– peptide drug conjugates. Mol Ther 23(5):907–917. https://doi.org/10.1038/mt.2015.22
Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC (2014) Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev 66:2–25. https://doi.org/10.1016/j.addr.2013.11.009
Bhargava A, Mishra DK, Jain SK, Srivastava RK, Lohiya NK et al (2016) Comparative assessment of lipid-based nano-carrier systems for dendritic cell-based targeting of tumor re-initiating cells in gynecological cancers. Mol Immunol 79:98–112. https://doi.org/10.1016/j.molimm.2016.10.003
Bouzid R, Peppelenbosch M, Buschow SI (2020) Opportunities for conventional and in situ cancer vaccine strategies and combination with immunotherapy for gastrointestinal cancers, a review. Cancers (basel) 12(5):1121. https://doi.org/10.3390/cancers12051121
Byrne JD, Betancourt T, Brannon-Peppas L (2008) Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 60(15):1615–1626. https://doi.org/10.1016/j.addr.2008.08.005
Cai H, Wang X, Zhang H, Sun L, Pan D et al (2018) Enzyme-sensitive biodegradable and multifunctional polymeric conjugate as theranostic nanomedicine. Appl Mater Today 11:207–218. https://doi.org/10.1016/j.apmt.2018.02.003
Chandra S, Nguyen HM, Wiltz K, Hall N, Chaudhry S et al (2020) Aptamer-functionalized hybrid nanoparticles to enhance the delivery of doxorubicin into breast cancer cells by silencing pglycoprotein. J Cancer Treatment Diagn 4(1):1–13. https://doi.org/10.29245/2578-2967/2020/1.1176
Chaudhary AK, Chaudhary S, Ghosh K, Nadkarni A (2016) Pleiotropic roles of metalloproteinases in hematological malignancies: an update. Asian Pac J Cancer Prev 17(7):3043–3051. https://doi.org/10.14456/apjcp.2016.51/APJCP.2016.17.7.3043
Chen B, Wang Z, Sun J, Song Q, He B et al (2016) A tenascin C targeted nanoliposome with navitoclax for specifically eradicating of cancer-associated fibroblasts. Nanotechnol Biol Med 12:131–141. https://doi.org/10.1016/j.nano.2015.10.001
Chen C, Sun J, Chen S, Liu Y, Zhu S et al (2019) A multifunctional-targeted nanoagent for dual-mode image-guided therapeutic effects on ovarian cancer cells. Int J Nanomed 14:753–769. https://doi.org/10.2147/IJN.S18792
Chen H, Sha H, Zhang L, Qian H, Chen F et al (2018) Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumorpenetrating bispecific recombinant protein. Int J Nanomed 13:5347–5359. https://doi.org/10.2147/IJN.S165109
Chen KJ, Plaunt AJ, Leifer FG, Kang JY, Cipolla D (2021) Recent advances in prodrug-based nanoparticle therapeutics. Eur J Pharm Biopharm 165:219–243. https://doi.org/10.1016/j.ejpb.2021.04.025
Chen Q, Xu L, Liang C, Wang C, Peng R et al (2016b) Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy. Nat Commun 7:13193. https://doi.org/10.1038/ncomms13193
Chen WC, Zhang AX, Li SD (2012) Limitations and niches of the active targeting approach for nanoparticle drug delivery. Eur J Nanomed 4(2–4):89–93. https://doi.org/10.1515/ejnm-2012-0010
Chen W, Luo G, Lei Q, Jia H, Hong S et al (2015) MMP-2 responsive polymeric micelles for cancer-targeted intracellular drug delivery. Chem Commun (camb) 51(3):465–468. https://doi.org/10.1039/C4CC07563C
Choudhury H, Pandey M, Chin PX, Phang YL, Cheah JY et al (2018) Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends. Drug Deliv Transl Res 8(5):1545–1563. https://doi.org/10.1007/s13346-018-0552-2
Clinical Trials Gov, NIH, US National Library of Medicine.
Conde J, Bao C, Tan Y, Cui D, Edelman ER et al (2015) Dual targeted immunotherapy via in vivo delivery of biohybrid RNAi-peptide nanoparticles to tumor-associated macrophages and cancer cells. Adv Funct Mater 25(27):4183–4194. https://doi.org/10.1002/adfm.201501283
Cramer JD, Burtness B, Ferris RL (2019) Immunotherapy for head and neck cancer: Recent advances and future directions. Oral Oncol 99:104460. https://doi.org/10.1016/j.oraloncology.2019
Cruz A, Mota P, Ramos C, Pires RF, Mendes C et al (2020) Polyurea dendrimer folate-targeted nanodelivery of l-buthionine sulfoximine as a tool to tackle ovarian cancer chemoresistance. Antioxidants 9(133):1–13. https://doi.org/10.3390/antiox9020133
Cui J, Alt K, Ju Y, Gunawan ST, Braunger JA et al (2019) Ligand-functionalized poly (ethylene glycol) particles for tumor targeting and intracellular uptake. Biomacromol 20(9):3592–3600. https://doi.org/10.1021/acs.biomac.9b00925
Cui N, Hu M, Khalil RA (2017) Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci 147:1–73. https://doi.org/10.1016/bs.pmbts.2017.02.005
Dai L, Li K, Li M, Zhao X, Luo Z et al (2018) Size/charge changeable acidity-responsive micelleplex for photodynamic-improved PD-L1 immunotherapy with enhanced tumor penetration. Adv Funct Mater 28:1707249. https://doi.org/10.1002/adfm.201707249
Dam GB, Van De Westerlo EM, Purushothaman A, Stan RV, Bulten J et al (2007) Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding. Am J Path 171(4):1324–1333. https://doi.org/10.2353/ajpath.2007.070111
Danhier F, Feron O, Préat V (2010) To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148(2):135–146. https://doi.org/10.1016/j.jconrel.2010.08.027
Das MK (2021) Multifunctional theranostic nanomedicines in cancer. Elsevier, New York
Dempke WCM, Fenchel K, Uciechowski P, Dale SP (2017) Second- and third-generation drugs for immuno-oncology treatment -the more the better. Eur J Cancer 74:55–72. https://doi.org/10.1016/j.ejca.2017.01.001
De Sanctis F, Ugel S, Facciponte J, Facciabene A (2018) The dark side of tumor-associated endothelial cells. Semin Immunol 35:35–47. https://doi.org/10.1016/j.smim.2018.02.002
Dmitriev OY, Lutsenko S, Muyldermans S (2016) Nanobodies as probes for protein dynamics in vitro and in cells. J Biol Chem 291(8):3767–3775. https://doi.org/10.1074/jbc.R115.679811
Dua P, Kang HS, Hong SM, Tsao MS, Kim S et al (2013) Alkaline phosphatase ALPPL-2 is a novel pancreatic carcinoma-associated protein. Cancer Res 73(6):1934–1945. https://doi.org/10.1158/0008-5472.CAN-12-3682
Eggen S, Afadzi M, Nilssen EA, Haugstad SB, Angelsen B et al (2012) Ultrasound mediated delivery of liposomal doxorubicin in prostate tumor tissue. IEEE Int Ultrasonics Symp Proc 2012:436–439. https://doi.org/10.1109/ULTSYM.2012.0108
Emamzadeh M, Emamzadeh M, Pasparakis G (2019) Dual controlled delivery of gemcitabine and cisplatin using polymer-modified thermosensitive liposomes for pancreatic cancer. ACS Appl Bio Mater 2:1298–1309. https://doi.org/10.1021/acsabm.9b00007
Enyedi KN, Toth S, Szakacs G, Ező G (2017) NGR-peptide−drug conjugates with dual targeting properties. PLoS ONE 12(6):e0178632. https://doi.org/10.1371/journal.pone.0178632
Eskandari S, Guerin T, Toth I, Stephenson RJ (2017) Recent advances in self-assembled peptides: implications for targeted drug delivery and vaccine engineering. Adv Drug Deliv Rev 110–111:169–187. https://doi.org/10.1016/j.addr.2016.06.013
Esposito CL, Catuogno S, Condorelli G, Ungaro P, Franciscis VD (2018a) Aptamer chimeras for therapeutic delivery: the challenging perspectives. Genes 529:1–20. https://doi.org/10.3390/genes9110529
Esposito CL, Nuzzo S, Catuogno S, Romano S, Nigris FD et al (2018b) STAT3 gene silencing by aptamersiRNA chimera as selective therapeutic for glioblastoma. Mol Ther Nucleic Acids 10:398–411. https://doi.org/10.1016/j.omtn.2017.12.021
Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HC et al (2013) Acidity generated by the tumor microenvironment drives local invasion. Cancer Res 73:1524–1535. https://doi.org/10.1158/0008-5472.CAN-12-2796
Fais S, Venturi G, Gatenby B (2014) Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy. Cancer Metastasis Rev 33:1095–1108. https://doi.org/10.1007/s10555-014-9534-0
Fan X, Wang L, Guo Y, Xiong X, Zhu L et al (2016) Inhibition of prostate cancer growth using doxorubicin assisted by ultrasound-targeted nanobubble destruction. Internat J Nanomed 11:3585. https://doi.org/10.2147/IJN.S111808
Fang RH, Kroll AV, Zhang L (2015) Nanoparticle-based manipulation of antigen presenting cells for cancer immunotherapy. Small 11(41):5483–5496. https://doi.org/10.1002/smll.201501284
Feng B, Zhou F, Hou B, Wang D, Wang T et al (2018) Binary cooperative prodrug nanoparticles improve immunotherapy by synergistically modulating immune tumor microenvironment. Adv Mater 30(38):e1803001. https://doi.org/10.1002/adma.201803001
Feuerecker B, Seid C, Pirsig S, Bruchelt G, Senekowitsch-Schmidtke R (2015) DCA promotes progression of neuroblastoma tumors in nude mice. Am J Cancer Res 5(2):812–820
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE et al (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806–811. https://doi.org/10.1038/35888
Firer MA, Gellerman G (2012) Targeted drug delivery for cancer therapy: the other side of antibodies. J Hematol Oncol 5:70. https://doi.org/10.1186/1756-8722-5-70
Fitzgerald KA, Malhotra M, Gooding M, Sallas F, Evans JC et al (2016) A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor. Int J Pharm 499(1–2):131–145. https://doi.org/10.1016/j.ijpharm.2015.12.05
Fong YT, Chen CH, Chen JP (2017) Intratumoral Delivery of doxorubicin on folate-conjugated graphene oxide by in-situ forming thermo-sensitive hydrogel for breast cancer therapy. Nanomaterials 7(388):1–24. https://doi.org/10.3390/nano7110388
Fu C, Duan X, Cao M, Jiang S, Ban X et al (2019) Targeted magnetic resonance imaging and modulation of hypoxia with multifunctional hyaluronic Acid-MnO2 nanoparticles in glioma. Adv Healthcare Mater 8:1900047. https://doi.org/10.1002/adhm.201900047
Fu J, Zhang J, Li S, Zhang L, Lin L et al (2018) CuS nanodots loaded thermosensitive hydrogel for anti-cancer photothermal therapy. Mol Pharmaceutics 15(10):4621–4631. https://doi.org/10.1021/acs.molpharmaceut.8b00624
Fua Y, Jang MS, Wu T, Lee JH, Li Y et al (2019) Multifunctional hyaluronic acid-mediated quantum dots for targeted intracellular protein delivery and real-time fluorescence imaging. Carbohydr Polym 224:115174. https://doi.org/10.1016/j.carbpol.2019.115174
Gang G, Ziqi F, Yihuan N, Cancan Y, Baolin Z et al (2021) Optimization, characterization and in vivo evaluation of paclitaxel-loaded folate-conjugated superparamagnetic iron oxide nanoparticles. Int J Nanomed 16:2283–2295. https://doi.org/10.2147/IJN.S287434
Gao D, Gao J, Xu M, Cao Z, Zhou L et al (2017a) Targeted ultrasound-triggered phase transition nanodroplets for Her2-overexpressing breast cancer diagnosis and gene transfection. Mol Pharm 14(4):984–998. https://doi.org/10.1021/acs.molpharmaceut.6b00761
Gao F, Zhang J, Fu C, Xie X, Peng F et al (2017b) iRGD-modified lipid–polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability. Int J Nanomed 12:4147–4162. https://doi.org/10.2147/IJN.S134148
Gao S, Yang D, Fang Y, Lin X, Jin X et al (2019) Engineering nanoparticles for targeted remodeling of the tumor microenvironment to improve cancer immunotherapy. Theranostics 9(1):126–151. https://doi.org/10.7150/thno.29431
García MC, Naitlho N, Calderón-Montaño JM, Drago E, Rueda M et al (2021) Cholesterol levels affect the performance of AuNPs-decorated thermo-sensitive liposomes as nanocarriers for controlled doxorubicin delivery. Pharmaceutics 13(973):1–22. https://doi.org/10.3390/pharmaceutics130709
Ghedira D, Voissiere D, Peyrode C, Kraiem J, Gerard Y et al (2018) Structure-activity relationship study of hypoxia-activated prodrugs for proteoglycan-targeted chemotherapy in chondrosarcoma. Eur J Med Chem 158:51–67. https://doi.org/10.1016/j.ejmech.2018.08.060
Ghorbani M, Hamishehkar M (2019) Redox-responsive smart nanogels for intracellular targeting of therapeutic agents: applications and recent advances. J Drug Target 27(4):408–422. https://doi.org/10.1080/1061186X.2018.1514041
Gilabert-Oriol R, Ryan GM, Leung AWY, Firmino NS, Bennewith KL et al (2018) Liposomal Formulations to Modulate the Tumor Microenvironment and Antitumor Immune Response. Int J Mol Sci 19(10):2922. https://doi.org/10.3390/ijms19102922
Gilad Y, Firer M, Gellerman G (2016) Recent innovations in peptide based targeted drug delivery to cancer cells. Biomedicines 4(2):11. https://doi.org/10.3390/biomedicines4020011
Goel S, England CG, Chen F, Cai W (2016) Positron emission tomography and nanotechnology: a dynamic duo for cancer theranostics. Adv Drug Deliv Rev 113:157–176. https://doi.org/10.1016/j.addr.2016.08.001
Golombek SK, May JN, Theek B, Appold L, Drude N et al (2018) Tumor targeting via EPR: strategies to enhance patient responses. Adv Drug Deliv Rev 130:17–38. https://doi.org/10.1016/j.addr.2018.07.007
Grau M, Walker PR, Derouazi M (2018) Mechanistic insights into the efficacy of cell penetrating Peptide-based cancer vaccines. Cell Mol Life Sci 75(16): 2887–2896. https://doi.org/10.1007/s00018-018-2785-0
Greco KA, Franzen CA, Foreman KE, Flanigan FC, Kuo PC et al (2016) PLK-1 silencing in bladder cancer by siRNA delivered with exosomes. Urology 91:241.e1–7. https://doi.org/10.1016/j.urology.2016.01.028
Greish K (2007) Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target 15(7–8):457–464. https://doi.org/10.1080/10611860701539584
Guidry EN, Farand J, Soheili A, Parish CA, Kevin NJ et al (2014) Improving the in vivo therapeutic index of siRNA polymer conjugates through increasing pH responsiveness. Bioconjug Chem 25(2):296–307. https://doi.org/10.1021/bc400442p
Guo X, Li D, Yang G, ShiC TZ (2014) Thermo-triggered Drug Release from Actively Targeting Polymer Micelles. ACS Appl Mater Interfaces 6:8549–8559. https://doi.org/10.1021/am501422r
Haghiralsadat F, Amoabediny G, Naderinezhad S, Nazmi K, De Boer JP et al (2017) Eph A2 targeted doxorubicin—nanoliposomes for osteosarcoma treatment. Pharm Res 34:2891–2900. https://doi.org/10.1007/s11095-017-2272-6
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674. https://doi.org/10.1016/j.cell.2011.02.013
Hare JI, Lammers T, Ashford MB, Puri S, Storm G et al (2017) Challenges and strategies in anti-cancer nanomedicine development: an industry perspective. Adv Drug Deliv Rev 108:25–38. https://doi.org/10.1016/j.addr.2016.04.025
Harguindey S, Koltai T, Reshkin SJ (2018) Curing cancer? Further along the new pH-centric road and Paradigm. Oncoscience 5:132–133. https://doi.org/10.18632/oncoscience.422
Harisi R, Jeney A (2015) Extracellular matrix as target for antitumor therapy. Onco Targets Ther 8:1387–1398. https://doi.org/10.2147/OTT.S48883
Hashemzadeh N, Dolatkhah M, Aghanejad A, Barzegar-Jalali M, Omidi Y et al (2021) Folate receptor-mediated delivery of 1-MDT-loaded mesoporous silica magnetic nanoparticles to target breast cancer cells. Nanomedicine (lond) 16(24):2137–2154. https://doi.org/10.2217/nnm-2021-0176
He B, Jia Z, Du W, Yu C, Fan Y et al (2013) The transport pathways of polymer nanoparticles in MDCK epithelial cells. Biomaterials 34:4309–4326. https://doi.org/10.1016/j.biomaterials.2013.01.100
He C, Duan X, Guo N, Chan C, Poon C et al (2016) Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy. Nat Commun 7:12499. https://doi.org/10.1038/ncomms12499
Hellmann I, Waldmeier L, Bannwarth-Escher M, Maslova K, Wolter FI et al (2018) Novel antibody drug conjugates targeting tumor-associated receptor tyrosine kinase ROR2 by functional screening of fully human antibody libraries using transpo-mab display on progenitor B cells. Front Immunol 9:2490. https://doi.org/10.3389/fimmu.2018.02490
Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L et al (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci 95:4607–4612. https://doi.org/10.1073/pnas.95.8.4607
Hori S, Herrera A, Rossi JJ, Zhou J (2018) Current advances in aptamers for cancer diagnosis and therapy. Cancers 10:9. https://doi.org/10.3390/cancers10010009
Hossen S, Hossain MK, Basher MK, Mia MNH, Rahman MT et al (2018) Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: a review. J Adv Res 15:1–18. https://doi.org/10.1016/j.jare.2018.06.005
Hou J, Yu X, Shen Y, Shi Y, Su C et al (2017) Triphenyl phosphine-functionalized chitosan nanoparticles enhanced antitumor efficiency through targeted delivery of doxorubicin to mitochondria. Nanoscale Res Lett 12(1):158. https://doi.org/10.1186/s11671-017-1931-1
Hu N, Li W, Hong Y, Zeng Z, Zhang J et al (2022) A PD1 targeted nano-delivery system based on epigenetic alterations of T cell responses in the treatment of gastric cancer. Mol Ther: Oncolytics 24:148–159. https://doi.org/10.1016/j.omto.2021.12.006
Hu Q, Kang T, Feng J, Zhu Q, Jiang T et al (2016) Tumor Microenvironment and angiogenic blood vessels dual-targeting for enhanced anti-glioma therapy. ACS Appl Ater Interfaces 8:23568–23579. https://doi.org/10.1021/acsami.6b08239
Huang D, Zhuang Y, Shen H, Yang F, Wang X et al (2018) Acetal-linked PEGylated paclitaxel prodrugs forming freepaclitaxel-loaded pH-responsive micelles with high drug loading capacity and improved drug delivery. Mater Sci Eng C 82:60–68. https://doi.org/10.1016/j.msec.2017.08.063
Huang JL, Jiang G, Song QX, Gu X, Hu M et al (2017) Lipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via micropinocytosis. Nat Commun 8:15144. https://doi.org/10.1038/ncomms15144
Huang Z, Zhang Z, Jiang Y, Zhang D, Chen J et al (2012) Targeted delivery of oligonucleotides into tumorassociated macrophages for cancer. J Control Release 158(2):286–292. https://doi.org/10.1016/j.jconrel.2011.11.013
Huber A, Dammeijer F, Aerts JGJV, Vroman H (2018) Current state of dendritic cell-based immunotherapy: opportunities for in vitro antigen loading of different DC subsets. Front Immunol 9:2804. https://doi.org/10.3389/fimmu.2018.02804
Iezzi ME, Policastro L, Werbajh S, Podhajcer O, Canziani GA (2018) Single-domain antibodies and the promise of modular targeting in cancer imaging and treatment. Front Immunol 9:273. https://doi.org/10.3389/fimmu.2018.00273
Iranpour S, Nejati V, Delirezh N, Biparva P, Shirian S (2016) Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens. J Exp Clin Cancer Res 35(1):168. https://doi.org/10.1186/s13046-016-0444-6
Jalalian SH, Ramezani M, Abnous K, Taghdisi SM (2018) Targeted co-delivery of epirubicin and NAS-24 aptamer to cancer cells using selenium nanoparticles for enhancing tumor response in vitro and in vivo. Cancer Lett 416:8793. https://doi.org/10.1016/j.canlet.2017.12.023
Jeong Y, Hwang HS, Na K (2018) Theranostics and contrast agents for magnetic resonance imaging. Biomater Res 22(20):1–13
Jha A, Viswanadh MK, Burande AS, Mehata AK, Poddar S et al (2020) DNA biodots based targeted theranostic nanomedicine for the imaging and treatment of non-small cell lung cancer. Int J Biol Macromol 150:413–425. https://doi.org/10.1016/j.ijbiomac.2020.02.075
Jhaveri A, Deshpande P, Pattni B, Torchilin V (2018) Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma. J Control Release 277:89–101. https://doi.org/10.1016/j.jconrel.2018.03.006
Jin R, Yang X, Zhao D, Hou X, Li C et al (2019) An injectable hybrid hydrogel based on a genetically engineered polypeptide for second near-infrared fluorescence/photoacoustic imaging-monitored sustained chemo photothermal therapy. Nanoscale 11:16080–16091. https://doi.org/10.1039/c9nr04630e
Joshi BP, Wang TD (2018) Targeted optical imaging agents in cancer: focus on clinical applications. Contrast Media Mol Imaging 2015237:1–19. https://doi.org/10.1155/2018/2015237
Kalafat VD, Giralt E (2017) Cell-penetrating peptides: design strategies beyond primary structure and amphipathicity. Molecules 22(11):19–29. https://doi.org/10.3390/molecules22111929
Kalhapure RS, Renukuntla J (2018) Thermo- and pH dual responsive polymeric micelles and nanoparticles. ChemicoBiological Interactions 295:20–37. https://doi.org/10.1016/j.cbi.2018.07.016
Kalimuthu K, Lubin BC, Bazylevich A, Gellerman G, Shpilberg O et al (2018) Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells. J Nanobiotechnol 16(1):34
Kalyane D, Raval N, Maheshwari R, Tambe V, Kalia R et al (2019) Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Mater Sci Eng C 98:1252–1276. https://doi.org/10.1016/j.msec.2019.01.066
Kanamala M, Palmer BD, Jamieson SM, Wilson WR, Wu Z (2019) Dual pH-sensitive liposomes with low pH-triggered sheddable PEG for enhanced tumor-targeted drug delivery. Nanomedicine (lond) 14(15):1971–1989. https://doi.org/10.2217/nnm-2018-0510
Kanapathipillai M, Mammoto A, Mammoto T, Kang JH, Jiang E et al (2012) Inhibition of mammary tumor growth using lysyl oxidase- targeting nanoparticles to modify extracellular atrix. Nano Lett 12:3213–3217. https://doi.org/10.1021/nl301206p
Kang C, Cho W, Park M, Kim J, Park S et al (2016a) H2O2-triggered bubble generating antioxidant polymeric nanoparticles as ischemia/reperfusion targeted nanotheranostics. Biomaterials 85:195–203. https://doi.org/10.1016/j.biomaterials.2016.01.070
Kang T, Zhu Q, Jiang D, Feng X, Feng J et al (2016b) Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment. Biomaterials 101:60–75. https://doi.org/10.1016/j.biomaterials.2016.05.037
Kim H, Hwang D, Choi M, Lee S, Kang S et al (2019) Antibody-assisted delivery of a peptide−drug conjugate for targeted cancer therapy. Mol Pharmaceutics 16:165–172. https://doi.org/10.1021/acs.molpharmaceut.8b00924
Kim MS, Lee DW, Park K, Park SJ, Choi EJ et al (2014) Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes. Colloids Surf B 116:1725. https://doi.org/10.1016/j.colsurfb.2013.12.045
Klein D (2018) The tumor vascular endothelium as decision maker in cancer therapy. Front Oncol 8:367. https://doi.org/10.3389/fonc.2018.00367
Koirala N, Das D, Fayazzadeh E, Sen S, McClain A et al (2019) Folic acid conjugated polymeric drug delivery vehicle for targeted cancer detection in hepatocellular carcinoma. J Biomed Mater Res A 107(11):2522–2535. https://doi.org/10.1002/jbm.a.36758
Koltai T (2016) Cancer: fundamentals behind pH targeting and the double-edged approach. Onco Targets Ther 9:6343–6360. https://doi.org/10.2147/OTT.S115438
Kono K, Takashima M, Yuba E, Harada A, Hiramatsu Y et al (2015) Multifunctional liposomes having target specificity, temperature-triggered release, and near-infrared fluorescence imaging for tumor-specific chemotherapy. J Control Release 216:69–77. https://doi.org/10.1016/j.jconrel.2015.08.005
Kotopoulis S, Dimcevski G, Gilja OH, Hoem D, Postema M (2013) Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study. Med Phys 40(7):072902. https://doi.org/10.1118/1.4808149
Kratschmer C, Ley M (2018) Targeted delivery of auristatin-modified toxins to pancreatic cancer using aptamers. Mol Ther Nucleic Acids 10:227–236. https://doi.org/10.1016/j.omtn.2017.11.013
Ku HS, Jo SD, Lee YK, Kim K, Kim SH (2016) Chemical and structural modifications of RNAi therapeutics. Adv Drug Deliv Rev 104:16–28. https://doi.org/10.1016/j.addr.2015.10.015
Kumar P, Paknikara KM, Gajbhiye V (2018) A robust pH-sensitive unimolecular dendritic nanocarrier that enables targeted anti-cancer drug delivery via GLUT transporters. Colloids Surf B 171:437–444. https://doi.org/10.1016/j.colsurfb.2018.07.053
Kutova OM, Guryev EL, Sokolova EA, Alzeibak R, Balalaeva IV (2019) Targeted delivery to tumors: multidirectional strategies to improve treatment efficiency. Cancers (basel) 11(68):1–33. https://doi.org/10.3390/cancers11010068
Ladju RB, Pascut D, Massi MN, Tiribelli C, Sukowati CHC (2018) Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma. Oncotarget 9:2951–2961. https://doi.org/10.18632/oncotarget.24572
Lampi MC, Reinhart-King CA (2018) Targeting extracellular matrix stiffness to attenuate disease: from molecular mechanisms to clinical trials. Sci Transl Med 10(422):0475. https://doi.org/10.1126/scitranslmed.aao0475
Lan G, Ni K, Xu Z, Veroneau SV, Song Y et al (2018) Nanoscale metal−organic framework overcomes hypoxia for Photodynamic therapy primed cancer immunotherapy. J Am Chem Soc 140:5670–5673. https://doi.org/10.1021/jacs.8b01072
Large DA, Soucy JR, Hebert J, Auguste DT (2018) Advances in receptor-mediated, tumor-targeted drug delivery. Adv Therap 1800091:1–27
LeCher JC, Nowak SJ, McMurry JL (2017) Breaking in and busting out: cell-penetrating peptides and the endosomal escape problem. BioMol Concepts 8(3–4):131–141. https://doi.org/10.1515/bmc-2017-0023
Lee K, David AE, Zhang J, Shin MC, Yang VC (2017) Enhanced accumulation of theranostic nanoparticles in brain tumor by external magnetic field mediated in situ clustering of magnetic nanoparticles. J Ind Eng Chem 54:389–397. https://doi.org/10.1016/j.jiec.2017.06.019
Lee SY, Yang CY, Peng CL, Wei MF, Chen KC et al (2016) A theranostic micelleplex codelivering SN-38 and VEGF siRNA for colorectal cancer therapy. Biomaterials 86:92–105. https://doi.org/10.1016/j.biomaterials.2016.01.068
Legge CJ, Colley HE, Lawson MA, Rawlings AE (2019) Targeted magnetic nanoparticle hyperthermia for the treatment of oral cancer. J Oral Pathol Med 48:803–809
Lei Y, Tang L, Xie Y, Xianyu Y, Zhang L et al (2017) Gold nanoclustersassisted delivery of NGF siRNA for effective treatment of pancreatic cancer. Nat Commun 8:15130. https://doi.org/10.1038/ncomms15130
Leite Nascimento T, Hillaireau H, Vergnaud J, Rivano M, Deloménie C et al (2016) Hyaluronic acid-conjugated lipoplexes for targeted delivery of siRNA in a murine metastatic lung cancer model. Int J Pharm 514(1):103–111. https://doi.org/10.1016/j.ijpharm.2016.06.125
Li B, Cai M, Lin L, Sun W, Zhou Z et al (2019a) MRI-visible and pH-sensitive micelles loaded with doxorubicin for hepatoma treatment. Biomater Sci 7:1529–1542. https://doi.org/10.1039/c8bm01501e
Li G, Gao Y, Gong C, Han Z, Qiang Q (2019b) Dual-blockade immune checkpoint for breast cancer treatment based on a tumor-penetrating peptide assembling nanoparticle. ACS Appl Mater Interfaces 11(43):39513–39524. https://doi.org/10.1021/acsami.9b13354
Li G, Liu D, Kimchi ET, Kaifi JF, Qi X et al (2018a) Nanoliposome C6-ceramide increases the anti-tumor immune response and slows growth of liver tumors in mice. Gastroenterology 154(4):1024–1036. https://doi.org/10.1053/j.gastro.2017.10.050
Li M, Bu W, Ren J, Li J, Deng L et al (2018b) Enhanced synergism of thermo-chemotherapy for liver cancer with magnetothermally responsive nanocarriers. Theranostics 8(3):693–709
Li M, Deng L, Li J, Yuan W, Gao X et al (2018c) Actively targeted magnetothermally responsive nanocarriers/ doxorubicin for thermochemotherapy of hepatoma. ACS Appl Mater Interfaces 10:41107−41117. https://doi.org/10.1021/acsami.8b14972
Li S, Sun Z, Deng G, Meng X, Li WL et al (2017a) Dual-modal imaging-guided highly efficient photothermal therapy using heptamethine cyanine-conjugated hyaluronic acid micelles. Biomater Sci 5(6):1122–1129. https://doi.org/10.1039/C7BM00230K
Li S, Wang L, Li N, Liu Y, Su Y (2017b) Combination lung cancer chemotherapy: design of a pH-sensitive transferrin-PEGHz-lipid conjugate for the co-delivery of docetaxel and baicalin. Biomed Pharmacother 95:548–555. https://doi.org/10.1016/j.biopha.2017.08.090
Li W, Cai X, Kim C, Sun G, Zhang Y et al (2011) Gold nanocages covered with thermally responsive polymers for controlled release by high-intensity focused ultrasound. Nanoscale 3(4):1724–1730. https://doi.org/10.1039/C0NR00932F
Li WQ, Wang Z, Hao S, He H, Wan Y et al (2017c) Mitochondria-targeting polydopamine nanoparticles to deliver doxorubicin for overcoming drug resistance. ACS Appl Mater Interfaces 9:16793–16802. https://doi.org/10.1021/acsami.7b01540
Li Y, Zheng X, Gong M, Zhang J (2016) Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma. Oncotarget 7(48):79401–79407. https://doi.org/10.18632/oncotarget
Liang H, Li X, Wang B, Chen B, Zhao Y et al (2016) A collagen-binding EGFR antibody fragment targeting tumors with a collagen-rich extracellular matrix. Sci Rep 6:18205. https://doi.org/10.1038/srep18205
Liang J, Huang Q, Hua C, Hu J, Chen B et al (2019) pH-Responsive nanoparticles loaded with graphene quantum dots and doxorubicin for intracellular imaging drug delivery efficient cancer therapy. Chem Select 4:6004–6012. https://doi.org/10.1002/slct.201803807
Liang J, Yang X, Liu D, Cong M, Song Y et al (2020) Lipid/hyaluronic acid-coated doxorubicin-Fe3O4 as a dual-targeting nanoparticle for enhanced cancer therapy. AAPS PharmSciTech 21(235):1–9. https://doi.org/10.1208/s12249-020-01764-3
Liang J, ZhangX MiaoY, Li J, Gan Y (2017) Lipid-coated iron oxide nanoparticles for dual-modal imaging of hepatocellular carcinoma. Int J Nanomed 12:2033–2044
Liang X, Wu B, Shang H, Han X, Jing H et al (2018) VTIQ evaluates antitumor effects of NET-1 siRNA by UTMD in HCC xenograft models. Oncol Lett 16(3):2893–2902. https://doi.org/10.3892/ol.2018.8994
Liberale G, Vankerckhove S, Caldon MG, Ahmed B, Moreau M et al (2016) Fluorescence imaging after indocyanine green injection for detection of peritoneal metastases in patients undergoing cytoreductive surgery for peritoneal carcinomatosis from colorectal cancer: a pilot study. Ann Surg 264(6):1110–1115. https://doi.org/10.1097/SLA.0000000000001618
Lin J, Shigdar S, Fang DZ, Xiang D, Wei MQ (2014) Improved efficacy and reduced toxicity of doxorubicin encapsulated in sulfatide-containing nanoliposome in a glioma model. PLoS ONE 9(7):e103736. https://doi.org/10.1371/journal.pone.0103736
Lin W, Yao N, Qian L, Zhang X, Chen Q et al (2017) pH-responsive unimolecular micelle-gold nanoparticles-drug nanohybrid system for cancer theranostics. Acta Biomater 58:455–465. https://doi.org/10.1016/j.actbio.2017.06.003
Lin X, Song X, Zhang Y, Cao Y, Xue Y et al (2020) Multifunctional theranostic nanosystems enabling photothermal-chemo combination therapy of triple-stimuli-responsive drug release with magnetic resonance imaging. Biomater Sci 8:1875–1884. https://doi.org/10.1039/C9BM01482A
Liu C, Yao S, Li X, Wang F, Jiang Y (2017) iRGD-mediated core-shell nanoparticles loading carmustine and O6benzylguanine for glioma therapy. J Drug Target 25(3):235–246. https://doi.org/10.1080/1061186X.2016.1238091
Liu J, Xu F, Huang J, Xu J, Liu Y et al (2018a) Lowintensity focused ultrasound (LIFU)-activated nanodroplets as a theranostic agent for noninvasive cancer molecular imaging and drug delivery. Biomater Sci 6:2838–2849. https://doi.org/10.1039/c8bm00726h
Liu Q, Chen X, Jia J, Zhang W, Yang T et al (2015) pH-Responsive poly (D, L-lactic-co-glycolic acid) nanoparticles with rapid antigen release behavior promote immune response. ACS Nano 9(5):4925–4938. https://doi.org/10.1021/nn5066793
Liu Y, Chen S, Sun J, Zhu S, Chen C et al (2019a) Folate-targeted and oxygen/indocyanine green-loaded lipid nanoparticles for dual-mode imaging and photo-sonodynamic/ photothermal therapy of ovarian cancer in vitro and in vivo. Mol Pharm 16(10):4104–4120. https://doi.org/10.1021/acs.molpharmaceut.9b00339
Liu Y, Gunda V, Zhu X, Xu X, Wu J et al (2016a) Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer. Proc Natl Acad Sci USA 113:7750–7755. https://doi.org/10.1073/pnas.1605841113
Liu Y, Zhao N, Xu FJ (2019b) pH-Responsive degradable dextran-quantum dot nanohybrids for enhanced gene delivery. ACS Appl Mater Interfaces 11(38):34707–34716. https://doi.org/10.1021/acsami.9b12198
Liu Y, Zhou C, Wang W, Yang J, Wang H et al (2016b) CD44 Receptor targeting and endosomal pHSensitive dual functional hyaluronic acid micelles for intracellular paclitaxel delivery. Mol Pharm 13(12):42094221. https://doi.org/10.1021/acs.molpharmaceut.6b00870
Liu Y, Zhou C, Wei S, Yang T, Lan Y et al (2018b) Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion. Colloids Surf B Biointerfaces 170:330–340. https://doi.org/10.1016/j.colsurfb.2018.06.024
Locatelli E, Li Y, Monaco I, Guo W, Maturi M et al (2019) A novel theranostic gold nanorods- and Adriamycin-loaded micelle for EpCAM targeting, laser ablation, and photoacoustic imaging of cancer stem cells in hepatocellular carcinoma. Int J Nanomed 14:1877–1892. https://doi.org/10.2147/IJN.S197265
López-Noriega A, Hastings CL, Ozbakir B, O’Donnell KE, O’Brien FJ et al (2014) Hyperthermia-induced drug delivery from thermosensitive liposomes encapsulated in an injectable hydrogel for local chemotherapy. Adv Healthc Mater 3(6):854–859. https://doi.org/10.1002/adhm.201300649
Lu P, Weaver VM, Werb Z (2012) The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 196(4):395–406. https://doi.org/10.1083/jcb.201102147
Luo M, Lewik G, Ratcliffe JC, Hang C, Choi J et al (2019) Systematic evaluation of transferrin-modified porous silicon nanoparticles for targeted delivery of doxorubicin to glioblastoma. ACS Appl Mater Interfaces 11(37):33637–33649. https://doi.org/10.1021/acsami.9b10787
Luo W, Wen G, Yang L, Tang J, Wang J et al (2017a) Dualtargeted and pH-sensitive doxorubicin prodrug-microbubble complex with ultrasound for tumor treatment. Theranostics 7(2):452–465. https://doi.org/10.7150/thno.16677
Luo X, Peng X, Hou J, Wu S, Shen J et al (2017b) Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer. Int J Nanomed 12:5331–5343. https://doi.org/10.2147/IJN.S137245
Ma Z, Hu P, Guo C, Wang D, Zhang X et al (2019) Folate-mediated and pH-responsive chidamidebound micelles encapsulating photosensitizers for tumor-targeting photodynamic therapy. Int J Nanomed 14:5527–5540. https://doi.org/10.2147/IJN.S208649
Mahajan UM, Teller S, Sendler M, Palankar R, Brandt CV (2016) Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer. Gut 65:1838–1849. https://doi.org/10.1136/gutjnl-2016-311393
Makhlouf A, Hajdu I, Hartimath SV, Alizadeh E, Wharton K et al (2019a) 111In-labeled glycoprotein nonmetastatic b (GPNMB) targeted gemini surfactant-based nanoparticles against melanoma. In vitro characterization and in vivo evaluation in melanoma mouse xenograft model. Mol Pharmaceutics 16:542–551. https://doi.org/10.1021/acs.molpharmaceut.8b00831
Makhlouf A, Hajdu I, Hartimath SV, Alizadeh E, Wharton K et al (2019b) 111In-Labeled Glycoprotein Nonmetastatic b (GPNMB) targeted gemini surfactant-based nanoparticles against melanoma: in vitro characterization and in vivo evaluation in melanoma mouse xenograft model. Mol Pharmaceutics 16(2):542–551. https://doi.org/10.1021/acs.molpharmaceut.8b00831
Marchetti C, Palaia I, Giorgini M, De Medici C, Iadarola R (2014) Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review. Onco Targets Ther 10(7):1223–1236. https://doi.org/10.2147/OTT.S40947
Marta GN, Hanna SA, Gadia R, Correa SF, Silva JL et al (2012) The role of radiotherapy in urinary bladder cancer: current status. Int Braz J Urol 38(2):144–153. https://doi.org/10.1590/s1677-55382012000200002
Mazzotta E, Tavano T, Muzzalupo R (2018) Thermo-sensitive vesicles in controlled drug delivery for chemotherapy. Pharmaceutics 10:150. https://doi.org/10.1016/j.jconrel.2018.09.031
Meel R, Vehmeijer LJC, Kok RJ, Storm G, Van Gaal EVB (2013) Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status. Adv Drug Deliv Rev 65:1284–1298. https://doi.org/10.1016/j.addr.2013.08.012
Meng F, Cheng R, Deng C, Zhong Z (2012) Intracellular drug release nanosystems. Mater Today 15(10):436442. https://doi.org/10.1016/S1369-7021(12)70195-5
Miller K, Cortes J, Hurvitz SA, Krop IE, Tripathy D et al (2016) HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician’schoice plus trastuzumab in patients with previously treated, anthracycline-naive, HER2-positive, locally advanced/metastatic breast cancer. BMC Cancer 16:352. https://doi.org/10.1186/s12885-016-2385-z
Minaei SE, Khoei S, Khoee S, Karimi MR (2019) Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma. Int J Biochem Cell Biol 108:72–83. https://doi.org/10.1016/j.biocel.2019.01.010
MinaeiSE KS, KhoeeS VF, Mahabadi VP (2019) in vitro anti-cancer efficacy of multi-functionalized magnetite nanoparticles combining alternating magnetic hyperthermia in glioblastoma cancer cells. Mater Sci Eng C 101:575–587
Minamino T, Komuro I, Kitakaze M (2010) Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease. Circ Res 107:1071–1082. https://doi.org/10.1161/CIRCRESAHA.110.227819
Mo L, Song JG, Lee H, Zhao M, Kim HY et al (2018) PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure. Nanomedicine 14(2):557–567. https://doi.org/10.1016/j.nano.2017.12.003
Moghimipour E, Rezaei M, Ramezani Z, Kouchak M, Amini M et al (2018) Transferrin targeted liposomal 5-fluorouracil induced apoptosis via mitochondria signaling pathway in cancer cells. Life Sci 194:104–110. https://doi.org/10.1016/j.lfs.2017.12.026
Mukerjee A, Ranjan AP, Vishwanatha JK (2016) Targeted nanocurcumin therapy using annexin A2 antibody improves tumor accumulation and therapeutic efficacy against highly metastatic breast cancer. J Biomed Nanotechnol 12:1374–1392. https://doi.org/10.1166/jbn.2016.2240
Murray-Stewart TR, Woster PM, Casero RA Jr (2016) Targeting polyamine metabolism for cancer therapy and prevention. Biochem J 473(19):2937–2953. https://doi.org/10.1042/BCJ20160383
Naba A, Clauser KR, Ding H, Whittaker CA, Carr SA et al (2016) The extracellular matrix: tools and insights for the “omics” era. Atrix Biol 49:10–24. https://doi.org/10.1016/j.matbio.2015.06.003
Nakamura T, Miyabe H, Hyodo M, Sato Y, Hayakawa Y et al (2015) Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma. J Control Release 216:149–157. https://doi.org/10.1016/j.jconrel.2015.08.026
Narmani A, Rezvani M, Farhood B, Darkhor P, Mohammadnejad J et al (2019) Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems. Drug Dev Res 80:404–424. https://doi.org/10.1002/ddr.21545
Nath A, Pal R, Singha LM, Saikia H, Rahaman H et al (2018) Gold-manganese oxide nanocomposite suppresses hypoxia and augments pro-inflammatory cytokines in tumor associated macrophages. Int Immunopharmacol 57:157–164. https://doi.org/10.1016/j.intimp.2018.02.021
Nel A, Ruoslahti E, Meng H (2017) New insights into “Permeability” as in the enhanced permeability and retention effect of cancer nanotherapeutics. ACS Nano 11:9567–9569. https://doi.org/10.1021/acsnano.7b07214
Nuhn L, Bolli E, Massa S, Vandenberghe I, Movahedi K et al (2018) Targeting protumoral tumor-associated macrophages with nanobody-functionalized nanogels through SPAAC ligation. Bioconjugate Chem 29(7):2394–2405. https://doi.org/10.1021/acs.bioconjchem.8b00319
Nykanen P (2003) Development of multiple-unit oral formulations for colon-specific drug delivery using enteric polymers and organic acids as excipients. Helsinki
Obeid MA, Elburi A, Young LC, Mullen AB, Tate RJ et al (2017) Formulation of nonionic surfactant vesicles (NISV) prepared by microfluidics for therapeutic delivery of siRNA into cancer cells. Mol Pharm 14(7):2450–2458. https://doi.org/10.1021/acs.molpharmaceut.7b00352
Okazaki S, Iwasaki T, Yuba E, Watarai S (2018) Evaluation of pH-sensitive fusogenic polymer-modified liposomes coloaded with antigen and α-galactosylceramide as an anti-tumor vaccine. J Vet Med Sci 80(2):197–204. https://doi.org/10.1292/jvms.17-0491
Ovais M, Guo M, Chen C (2019) Tailoring nanomaterials for targeting tumor-associated macrophages. Adv Mater 31(19):e1808303. https://doi.org/10.1002/adma.201808303
Overchuk M, Zheng G (2018) Overcoming obstacles in the tumor microenvironment: recent advancements in nanoparticle delivery for cancer theranostics. Biomaterials 156:217–237. https://doi.org/10.1016/j.biomaterials.2017.10.024
Parekh P, Kamble S, Zhao N, Zeng Z, Portier BP et al (2013) Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer. Biomaterials 34(35):8909–8917. https://doi.org/10.1016/j.biomaterials.2013.07.099
Paris JL, Mannaris C, Cabañas MV, Carlisle R, Manzano M et al (2018) Ultrasound mediated cavitation-enhanced extravasation of mesoporous silica nanoparticles for controlled-release drug delivery. Chem Eng J 340(15):2–8. https://doi.org/10.1016/j.cej.2017.12.051
Patel K, Doddapaneni R, Chowdhury N, Boakye CHA, Behl G et al (2016a) Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer. Nanomedicine (lond) 11:1377–1392. https://doi.org/10.2217/nnm.16.37
Patel K, Doddapaneni R, Sekar V, Chowdhury N, Singh M (2016b) Combination approach of YSA peptide anchored docetaxel stealth liposomes with oral antifibrotic agent for the treatment of lung cancer. Mol Pharm 3(6):2049–2058. https://doi.org/10.1021/acs.molpharmaceut.6b00187
Peña HDL, Madrigal JA, Rusakiewicz S, Bencsik M, Cave GWV et al (2009) Artificial exosomes as tools for basic and clinical immunology. J Immunol Methods 344:121–132. https://doi.org/10.1016/j.jim.2009.03.011
Peng N, Wu B, Wang L, He W, Ai Z et al (2016) High drug loading and pH-responsive targeted nanocarriers from alginate-modified SPIONs for anti-tumor chemotherapy. Biomater Sci 4:1802–1813. https://doi.org/10.1039/c6bm00504g
Pillai G (2014) Nanomedicines for cancer therapy: an update of FDA approved and those under various stages of development. SOJ Pharm Dev Sci 1(2):1–13. https://doi.org/10.15226/2374-6866/1/2/00109
Poh AR, Ernst M (2018) Targeting macrophages in cancer: from bench to bedside. Front Oncol 8:49. https://doi.org/10.3389/fonc.2018.00049
Pourjavadi A, Amin SP, Hosseini SH (2018) Delivery of hydrophobic anticancer drugs by hydrophobically modified alginate based agnetic nanocarrier. Ind Eng Chem Res 57:822–832. https://doi.org/10.1021/acs.iecr.7b04050
Powell D, Chandra S, Dodson K, Shaheen F, Wilt K et al (2017) Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer. Eur J Pharm Biopharm 114:108–118. https://doi.org/10.1016/j.ejpb.2017.01.011
Prabhakar U, Blakey DC, Maeda H, Jain RK, Sevick-Muraca EM et al (2013) Challenges and key considerations of the enhanced permeability and retention effect (EPR) for nanomedicine drug delivery in oncology. Cancer Res 73:2412–2417. https://doi.org/10.1158/0008-5472.CAN-124561
Pu X, Zhao L, Li J, Song R, Wang Y et al (2019) A polymeric micelle with an endosomal pH-sensitivity for intracellular delivery and enhanced antitumor efficacy of hydroxycamptothecin. Acta Biomater 88:357–369. https://doi.org/10.1016/j.actbio.2019.02.039
Puri R, Adesina S, Akala E (2018) Cellular uptake and cytotoxicity studies of pH-responsive polymeric nanoparticles fabricated by dispersion polymerization. J Nanosci Nanomed 2(1):3–16
Qian Y, Qiao S, Dai Y, Xu G, Dai B et al (2017) Molecular-targeted immunotherapeutic strategy for melanoma via dual-targeting nanoparticles delivering small interfering RNA to tumor-associated macrophages. ACS Nano 11(9):9536–9549. https://doi.org/10.1021/acsnano.7b05465
Qin YT, Peng H, He XW, Li WY, Zhang YK (2019) pH-Responsive polymer-stabilized ZIF-8 nanocomposite for fluorescence and magnetic resonance dual-modal imaging-guided chemo/photodynamic combinational cancer therapy. ACS Appl Mater Interfaces 11:34268–34281. https://doi.org/10.1021/acsami.9b12641
Qiu J, Cheng R, Zhang J, Sun H, Deng C et al (2017) Glutathione-sensitive hyaluronic acid mercaptopurine prodrug linked via carbonyl vinyl sulfide: a robust and CD44-targeted nanomedicine for leukemia. Biomacromol 18:3207–3214. https://doi.org/10.1021/acs.biomac.7b00846
Raavé R, Van Kuppevelt TH, Daamen WF (2018) Chemotherapeutic drug delivery by tumoral extracellular matrix targeting. J Control Release 274:1–8. https://doi.org/10.1016/j.jconrel.2018.01.029
Racioppi M, D’Agostino D, Totaro A, Pinto F, Sacco E et al (2012) Value of current chemotherapy and surgery in advanced and metastatic bladder cancer. Urol Int 88:249–258. https://doi.org/10.1159/000335556
Ramzy L, Nasr M, Metwally AM, Awad GAS (2017) Cancer nanotheranostics: a review of the role of conjugated ligands for overexpressed receptors. Eur J Pharm Sci 104:273–292. https://doi.org/10.1016/j.ejps.2017.04.005
Raniolo S, Vindigni G, Ottaviani A, Unida V, Iacovelli F et al (2018) Selective targeting and degradation of doxorubicin-loaded folate-functionalized DNA nanocages. Nanomedicine 14(4):1181–1190. https://doi.org/10.1016/j.nano.2018.02.002
Rapoport NY, Kennedy AM, Shea JE, Scaife CL, Nam KH (2009) Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J Control Release 138:268–276. https://doi.org/10.1016/j.jconrel.2009.05.026
Ray S, Cheng CA, Chen W, Li Z, Zink JI et al (2019) Magnetic Heating stimulated cargo release with dose control using multifunctional MR and thermosensitive liposome. Nanotheranostics 3:166–178. https://doi.org/10.7150/ntno.31164
Reddy TL, Garikapati KR, Reddy KR, Reddy BVS, Yadav JS et al (2016) Simultaneous delivery of Paclitaxel and Bcl-2 siRNA via pH-Sensitive liposomal nanocarrier for the synergistic treatment of melanoma. Sci Rep 6:35223. https://doi.org/10.1038/srep35223
Ren XH, Wang HY, Li S, He XW, Li WY et al (2021) Preparation of glycan-oriented imprinted polymer coating Gd-doped silicon nanoparticles for targeting cancer: Tn antigens and dual-modal cell imaging via boronate-affinity surface imprinting. Talanta 223(1):121706. https://doi.org/10.1016/j.talanta.2020.121706
Riaz MK, Riaz MA, Zhang X, Lin C, Wong KH et al (2018) Surface functionalization and targeting strategies of liposomes in solid tumor therapy: a review. Int J Mol Sci 19:195. https://doi.org/10.3390/ijms19010195
Richards DA, Maruani A, Chudasama V (2017) Antibody fragments as nanoparticle targeting ligands: a step in the right direction. Chem Sci 8:63–77. https://doi.org/10.1039/c6sc02403c
Rios X, Compte M, Gómez-Vallejo V, Cossío U, Baz Z et al (2019) Immuno-PET imaging and pharmacokinetics of an anti-CEA scFv-based trimerbody and its monomeric counterpart in human gastric carcinoma-bearing mice. Mol Pharm 16:1025–1035. https://doi.org/10.1021/acs.molpharmaceut.8b01006
Rizvi SAA, Saleh AM (2018) Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J 26:64–70. https://doi.org/10.1016/j.jsps.2017.10.012
Rao NV, Ko H, Lee J, Park JH (2018) Recent progress and advances in stimuli-responsive polymers for cancer therapy. Front Bioeng Biotechnol 6:110. https://doi.org/10.3389/fbioe.2018.00110
Rosa JMR, Tirella A, Gennari A, Stratford IJ, Tirelli N (2017) The CD44-mediated uptake of hyaluronic acid-based carriers in macrophages. Adv Healthc Mater 6(4):1–11. https://doi.org/10.1002/adhm.201601012
Rosalia RA, Cruz LJ, Duikeren SV, Tromp AT, Silva AL et al (2015) CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses. Biomaterials 40:88–97. https://doi.org/10.1016/j.biomaterials.2014.10.053
Ruoslahti E (2017) Tumor penetrating peptides for improved drug delivery. Adv Drug Deliv Rev 110–111:3–12. https://doi.org/10.1016/j.addr.2016.03.008
Ryu K, Park J, Kim T (2019) Effect of pH-responsive charge-conversional polymer coating to cationic reduced graphene oxide nanostructures for tumor microenvironment-targeted drug delivery systems. Nanomaterials 9:1289. https://doi.org/10.3390/nano9091289
Sadeghi N, Deckers R, Ozbakir B, Akthar S, Kok RJ et al (2018) Influence of cholesterol inclusion on the doxorubicin release characteristics of lysolipid-based thermosensitive liposomes. Int J Pharm 548(2):778–782. https://doi.org/10.1016/j.ijpharm.2017.11.002
Sadr SH, Davaran S, Alizadeh E, Salehi R, Ramazani A (2018) Enhanced anticancer potency by thermo/pH responsive PCL-based magnetic nanoparticles. J Biomater Sci Polym Ed 29(3):277–308. https://doi.org/10.1080/09205063.2017.1414482
Sakhrani NM, Padh H (2013) Organelle targeting: third level of drug targeting. Drug Des Devel Ther 7:585–599. https://doi.org/10.2147/DDDT.S45614
Santos MA, Goertz DE, Hynynen K (2017) Focused ultrasound hyperthermia mediated drug delivery using thermosensitive liposomes and visualized with in vivo two-photon microscopy. Theranostics 7(10):2718–2731
Sardoiwala MN, Kushwaha AC, Dev A, Shrimali N, Guchhait P et al (2020) Hypericin-loaded transferrin nanoparticles induce PP2A-Regulated BMI1 degradation in colorectal cancer-specific chemophotodynamic therapy. ACS Biomater Sci Eng 6(5):3139–3153
Sau S, Alsaab HO, Bhise K, Alzhrani R, Nabil G et al (2018) Multifunctional nanoparticles for cancer immunotherapy: a groundbreaking approach for reprogramming malfunctioned tumor environment. J Control Release 274:24–34. https://doi.org/10.1016/j.jconrel.2018.01.028
Schneider-Futschik EK, Reyes-Ortega F (2021) Advantages and disadvantages of using magnetic nanoparticles for the treatment of complicated ocular disorders. Pharmaceutics 13(8):1157. https://doi.org/10.3390/pharmaceutics13081157
Schumann C, Chan C, Millar JA, Bortnyak Y, Carey K et al (2018) Intraperitoneal nanotherapy for metastatic ovarian cancer based on siRNA-mediated suppression of DJ-1 protein combined with a low dose of cisplatin. Nanomedicine 14(4):13951405. https://doi.org/10.1016/j.nano.2018.03.005
Senapati S, Mahanta AK, Kumar S, Maiti P (2018) Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther 3:7. https://doi.org/10.1038/s41392-017-0004-3
Sengupta S, Balla VK (2018) A review on the use of magnetic fields and ultrasound for non-invasive cancer treatment. J Adv Res 14:97–111. https://doi.org/10.1016/j.jare.2018.06.003
Senzer N, Nemunaitis J, Nemunaitis D, Bedell C, Edelman G et al (2013) Phase I study of a systemically delivered p53 nanoparticle in advanced solid tumors. Mol Ther 21(5):1096–1103. https://doi.org/10.1038/mt.2013.32
Serkova NJ (2017) Nanoparticle-based magnetic resonance imaging on tumor-associated macrophages and inflammation. Front Immunol 8:590. https://doi.org/10.3389/fimmu.2017.00590
Shabana AM, Kambhampati SP, Hsian RC, Kannan RM, Kokkoli E (2020) Thermosensitive and biodegradable hydrogel encapsulating targeted nanoparticles for the sustained CoDelivery of gemcitabine and paclitaxel to pancreatic cancer cells. Int J Pharm 593(120139):1–45. https://doi.org/10.1016/j.ijpharm.2020.120139
Shamsipour M, Mansouri AM, Moradipour P (2019) Temozolomide conjugated carbon quantum dots embedded in core/shell nanofibers prepared by coaxial electrospinning as an implantable delivery system for cell imaging and sustained drug release. AAPS PharmSciTech 20(259):1–14
Shen C, Wang X, Zheng Z, Gao C, Chen X et al (2019) Doxorubicin and indocyanine green loaded superparamagnetic iron oxide nanoparticles with PEGylated phospholipid coating for magnetic resonance with fluorescence imaging and chemotherapy of glioma. Int J Nanomed 14:101–117. https://doi.org/10.2147/IJN.S173954
Shen S, Ding B, Zhang S, Qi X, Wang K (2017) Near-infrared light-responsive nanoparticles with thermosensitive 2 yolk-shell structure for multimodal imaging and 3 chemo-photothermal therapy of tumor. Nanotechnol Biol Med 13(5):1607–1616. https://doi.org/10.1016/j.nano.2017.02.014
Shen Y, Li X, Dong D, Zhang B, Xue Y et al (2018a) Transferrin receptor 1 in cancer: a new sight for cancer therapy. Am J Cancer Res 8(6):916–931
Shen Y, Zhang J, Hao W, Wang T, Liu J et al (2018b) Copolymer micelles function as pH-responsive nanocarriers to enhance the cytotoxicity of a HER2 aptamer in HER2-positive breast cancer cells. Int J Nanomed 13:537–553. https://doi.org/10.2147/IJN.S149942
Shevtsov M, Pitkin E, Ischenko A, Stangl S, Khachatryan W et al (2019) Ex vivo Hsp70-activated NK cells in combination with PD-1 inhibition significantly increase overall survival in preclinical models of glioblastoma and lung cancer. Front Immunol 10:454. https://doi.org/10.3389/fimmu.2019.00454
Shi C, Liu T, Guo Z, Zhuang R, Zhang X et al (2018) Reprogramming tumor-associated macrophages by nanoparticle- based reactive oxygen species photogeneration. Nano Lett 18:7330–7342. https://doi.org/10.1021/acs.nanolett.8b03568
Shi D, Mi G, Shenb Y, Webster TJ (2019) Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood–brain barrier. Nanoscale 11:15057–15071. https://doi.org/10.1039/c9nr03931g
Shi J, Choi JL, Chou B, Johnson RN, Schellinger JG et al (2013) Effect of polyplex morphology on cellular uptake, intracellular trafficking, and transgene expression. ACS Nano 7(12):10612–10620. https://doi.org/10.1021/nn403069n
Shin LS, Nong LC, Yew M, Siong CW, Low LE (2021) Recent ultrasound advancements for the manipulation of nanobiomaterials and nanoformulations for drug delivery. Ultrason Sonochem 80:105805. https://doi.org/10.1016/j.ultsonch.2021
Shu G, Chen M, Song J, Xu X, Lu C et al (2020) Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe 3+ as a novel theranostic agent for T1/T2 dual-mode MRI-guided combined chemo-photothermal treatment of hepatic cancer. Bioact Mater 6(5):1423–1435. https://doi.org/10.1016/j.bioactmat.2020.10.020
Siegel R, Naishadham D, Jemal A (2012) Cancer statistics. CA Cancer J Clin 62(1):10–29. https://doi.org/10.3322/caac.20138
Siminzar P, Omidi Y, Golchin A, Aghanejad A, Barar J (2019) Targeted delivery of doxorubicin by magnetic mesoporous silica nanoparticles armed with mucin-1 aptamer. J Drug Targeting 28(1):92–101. https://doi.org/10.1080/1061186X.2019.1616745
Singh Y, Pawar VK, Meher JG, Raval K, Kumar A et al (2017) Targeting tumor associated macrophages (TAMs) via nanocarriers. J Control Release 254:92–106. https://doi.org/10.1016/j.jconrel.2017.03.395
Song M, Liu T, Shi C, Zhang X, Chen X (2016) Bioconjugated manganese dioxide nanoparticles enhance chemotherapy response by priming tumor-associated macrophages toward M1-like phenotype and attenuating tumor hypoxia. ACS Nano 10(1):633–647. https://doi.org/10.1021/acsnano.5b06779
Song J, Yang X, Yang Z, Lin L, Liu Y et al (2017) Rational design of branched nanoporous gold nanoshells with enhanced physico-optical properties for optical imaging and cancer therapy. ACS Nano 11(6):6102–6113. https://doi.org/10.1021/acsnano.7b02048
Song H, Huang P, Niu J, Shi G, Zhang C et al (2018) Injectable polypeptide hydrogel for dual-delivery of antigen and TLR3 agonist to modulate dendritic cells in vivo and enhance potent cytotoxic T-lymphocyte response against melanoma. Biomaterials 159:119–129. https://doi.org/10.1016/j.biomaterials.2018.01.004
Su S, Kang PM (2020) Recent advances in nanocarrier-assisted therapeutics delivery systems. Pharmaceutics 12(9):837. https://doi.org/10.3390/pharmaceutics12090837
Su Y, Hu S (2018) Functional nanoparticles for tumor penetration of therapeutics. Pharmaceutics 10:193. https://doi.org/10.3390/pharmaceutics10040193
Subhan MA, Yalamarty SSK, Filipczak N, Parveen F, Torchilin VP (2021) Recent advances in tumor targeting via EPR effect for cancer treatment. J Pers Med 11(6):571. https://doi.org/10.3390/jpm11060571
Sugahara KN, Teesalu T, Karmali PK, Kotamraju VR, Agemy L et al (2010) Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science 328:1031–1035. https://doi.org/10.1126/science.1183057
Suijkerbuijk SJE, Van RJ (2017) From good to bad: Intravital imaging of the hijack of physiological processes by cancer cells. Dev Biol 428:328–337. https://doi.org/10.1016/j.ydbio.2017.04.015
Sun L, Chen B, Jiang R, Li J, Wang B (2017) Resveratrol inhibits lung cancer growth by suppressing M2-like polarization of tumor associated macrophages. Cell Immunol 311:86–93. https://doi.org/10.1016/j.cellimm.2016.11.002
Sun N, Zhao L, Zhu J, Li Y, Song N et al (2019a) 131I-labeled polyethylenimine-entrapped gold nanoparticles for targeted tumor SPECT/CT imaging and radionuclide therapy. Int J Nanomed 14:4367–4381. https://doi.org/10.2147/IJN.S203259
Sun S, Chen J, Jiang K, Tang W, Wang Y et al (2019b) Ce6-Modified carbon dots for multimodal-imaging-guided and single-NIR-laser-triggered photothermal/photodynamic synergistic cancer therapy by reduced irradiation power. ACS Appl Mater Interfaces 11:5791–5803. https://doi.org/10.1021/acsami.8b19042
Sundarraj SM, Thangam R, Sujitha MV, Vimala K, Kannan S (2014) Ligand-conjugated mesoporous silica nanorattles based on enzymetargeted prodrug delivery system for effective lung cancer therapy. Toxicol Appl Pharmacol 275(3):232–243. https://doi.org/10.1016/j.taap.2014.01.012
Tan S, Li D, Zhu X (2020) Cancer immunotherapy: pros, cons and beyond. Biomed Pharmacother 124:109821. https://doi.org/10.1016/j.biopha.2020.109821
Tan S, Wang G (2018) Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin. Biomed Pharmacother 102:55–63. https://doi.org/10.1016/j.biopha.2018.03.046
Tang B, Zaro JL, Shen Y, Chen Q, Yu Y et al (2018) Acid-sensitive hybrid polymeric micelles containing a reversibly activatable cell-penetrating peptide for tumor-specific cytoplasm targeting. J Control Release 279:147–156. https://doi.org/10.1016/j.jconrel.2018.04.016
Tang L, Zhang F, Yu F, Sun W, Song M et al (2017) Croconaine nanoparticles with enhanced tumor accumulation for multimodality cancertheranostics. Biomaterials 129:28–36. https://doi.org/10.1016/j.biomaterials.2017.03.009
Tian Y, Guo R, Jiao Y, Sun Y, Shen S et al (2016) Redox stimuli-responsive hollow mesoporous silica nanocarriers for targeted drug delivery in cancer therapy. Nanoscale Horiz 1:480–487. https://doi.org/10.1039/C6NH00139D
Tian Y, Li S, Song J, Ji T, Zhu M et al (2014) A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35:2383–2390. https://doi.org/10.1016/j.biomaterials.2013.11.083
Tran S, DeGiovanni PJ, Piel B, Rai B (2017) Cancer nanomedicine: a review of recent success in drug delivery. Clin Trans Med 44:1–21. https://doi.org/10.1186/s40169-017-0175-0
Trinh TL, Zhu G, Xiao X, Puszyk W, Sefah K et al (2015) A synthetic aptamer-drug adduct for targeted liver cancer therapy. PLoS ONE 10(11):e0136673. https://doi.org/10.1371/journal.pone.0136673
Tu J, Zhang H, Yu J, Liufu C, Chen Z (2018) Ultrasound-mediated microbubble destruction: a new method in cancer immunotherapy. OncoTargets Ther 11:5763–5775. https://doi.org/10.2147/OTT.S171019
Tummers WS, Miller SE, Teraphongphom NT, Gomez A, Steinberg I et al (2018) Intraoperative pancreatic cancer detection using tumor-specific multimodality molecular imaging. Ann Surg Oncol 25(7):1880–1888
Ulbrich K, Hol K, Subr V, Bakandritsos A, Tucek J et al (2016) Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies. Chem Rev 116:5338–5431. https://doi.org/10.1021/acs.chemrev.5b00589
Upreti M, Jyoti A, Johnson SE, Swindell EP, Napier D et al (2016) Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer. Oncotarget 7(27):41559–41574. https://doi.org/10.18632/oncotarget.9490
Urandur S, Teja V, Ravi B, Shukla P, Gautam S et al (2020) Theranostic lyotropic liquid crystalline nanostructures for selective breast cancer imaging and therapy. Acta Biomater 113(1):522–540. https://doi.org/10.1016/j.actbio.2020.06.023
Valcourt DM, Harris J, Riley RS, Dang M, Wang J et al (2018) Advances in targeted nanotherapeutics: From bioconjugation to biomimicry. Nano Res 11(10):4999–5016. https://doi.org/10.1007/s12274-018-2083-z
Van der Steen SC, Raavé R, Langerak S, Van Houdt L, Van Duijnhoven SM (2017) Targeting the extracellular matrix of ovarian cancer using functionalized, drug loaded lyophilisomes. Eur J Pharm Biopharm 113:229–239. https://doi.org/10.1016/j.ejpb.2016
VanderSteen SC, Raavé R, Langerak S, van Houdt L, van Duijnhoven SM et al (2017) Targeting the extracellular matrix of ovarian cancer using functionalized, drug loaded lyophilisomes. Eur J Pharm Biopharm 113:229–239. https://doi.org/10.1016/j.ejpb.2016.12.01
Vandghanooni S, Eskandania M, Barara J, Omidi Y (2018) Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer. Eur J Pharm Sci 117:301–312. https://doi.org/10.1016/j.ejps.2018.02.027
Varma VNSK, Shivakumar HG, Fathima SJ, Radha V, Khanum F (2016) pH and thermosensitive 5-fluorouracil loaded poly (NIPAM-co-AAc) nanogels for cancer therapy. RSC Adv 6:105495–105507. https://doi.org/10.1039/C6RA18034E
Venugopal VP, Elangovana P, Sivasithambaram ND, Kunnathur MS (2018) Targeting apoptosis by 1,2-diazole through regulation of EGFR, Bcl-2 and CDK-2 mediated signaling pathway in human non-small cell lung carcinoma A549 cells. Gene 679:352–359. https://doi.org/10.1016/j.gene.2018.09.014
Voissiere A, Weber V, Gerard Y, Rédini F, Raes F et al (2017) Proteoglycan-targeting applied to hypoxia-activated prodrug therapy in chondrosarcoma: first proof-of-concept. Oncotarget 8(56):95824–95840. https://doi.org/10.18632/oncotarget.21337
Vrettos EI, Ező G, Tzakos AG (2018) On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site. Beilstein J Org Chem 14:930–954. https://doi.org/10.3762/bjoc.14.80
Wahajuddin AS (2012) Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomed 7:3445–3471. https://doi.org/10.2147/IJN.S30320
Wan Y, Dai W, Nevagi RJ, Toth L, Moyle PM (2017) Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells. Acta Biomater 59:257–268. https://doi.org/10.1016/j.actbio.2017.06.032
Wan WJ, Huang G, Wang Y, Tang Y, Li H et al (2021) Coadministration of iRGD peptide with ROS-sensitive nanoparticles co-delivering siFGL1 and siPD-L1 enhanced tumor immunotherapy. Acta Biomater 136:473–484. https://doi.org/10.1016/j.actbio.2021.09.040
Wang C, Wang X, Zhong T, Zhao Y, Zhang WQ et al (2015a) The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo. Int J Nanomedicine 10:2229–2248. https://doi.org/10.2147/IJN.S79840
Wang D, Wang T, Liu J, Yu H, Jiao S et al (2016a) Acid activatable versatile micelleplexes for PD-L1 blockade- enhanced cancer photodynamic immunotherapy. Nano Lett 16:5503–5513. https://doi.org/10.1021/acs.nanolett.6b01994
Wang RT, Zh XYS, Yao S, Zhang Y (2015b) LFC131 peptide-conjugated polymeric nanoparticles for the effective delivery of docetaxel in CXCR4 overexpressed lung cancer cells. Colloids Surf B Biointerfaces 133:43–50. https://doi.org/10.1016/j.colsurfb.2015.05.030
Wang S, Mei XG, Goldberg SN, Ahmed M, Lee JC et al (2016b) Does thermosensitive liposomal vinorelbine improve end-point survival after percutaneous radiofrequency ablation of liver tumors in a mouse model. Radiology 279:762–772. https://doi.org/10.1148/radiol.2015150787
Wang X, Li X, Mao Y, Wang D, Zhao Q et al (2019a) multi-stimuli responsive nanosystem modified by tumor-targeted carbon dots for chemophototherapy synergistic therapy. J Colloid Interface Sci 552:639–650. https://doi.org/10.1016/j.jcis.2019.05.085
Wang Y, Cheetham AG, Angacian G, Sua H, Xie L et al (2017a) Peptide-drug conjugates as effective prodrug strategies for targeted delivery. Adv Drug Deliv Rev 110–111:112–126. https://doi.org/10.1016/j.addr.2016.06.015
Wang Y, Khan A, Liu Y, Feng J, Dai L et al (2019b) Chitosan oligosaccharide-based dual pH responsive nano-micelles for targeted delivery of hydrophobic drugs. Carbohydr Polym 223:115061. https://doi.org/10.1016/j.carbpol.2019.115061
Wang Y, Lin YX, Qiao SL, An HW, Ma Y et al (2017b) Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment. Biomaterials 112:153–163. https://doi.org/10.1016/j.biomaterials.2016.09.034
Wang Y, Qiao SL, Wang H (2018) Facile synthesis of peptide cross-linked nanogels for tumor metastasis inhibition. ACS Appl Nano Ater 1:785–792. https://doi.org/10.1021/acsanm.7b00203
Wei X, Liao J, Davoudi Z, Zheng H, Chen J et al (2018) Folate Receptortargeted and GSH-responsive carboxymethyl chitosan nanoparticles containing covalently entrapped 6-mercaptopurine for enhanced intracellular drug delivery in leukemia. Mar Drugs 16(11):E439. https://doi.org/10.3390/md16110439
Wei Y, Xia H, Zhang F, Wang K, Luo P et al (2019) Theranostic nanoprobe mediated simultaneous monitoring and inhibition of p-glycoprotein potentiating multidrug-resistant cancer therapy. Anal Chem 91:11200–11208. https://doi.org/10.1021/acs.analchem.9b02118
Wickens J, Alsaab HO, Kesharwani P, Bhise K, Amin MCIM et al (2017) Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy. Drug Discov Today 22:665–680. https://doi.org/10.1016/j.drudis.2016.12.009
Wittrup A, Lieberman J (2015) Knocking down disease: a progress report on siRNA therapeutics. Nat Rev Genet 16(9):543–552. https://doi.org/10.1038/nrg3978
Wu B, Qiao Q, Han X, Jing H, Zhang H et al (2016) Targeted nanobubbles in low-frequency ultrasoundmediated gene transfection and growth inhibition of hepatocellular carcinoma cells. Tumor Biol 37:12113–12121. https://doi.org/10.1007/s13277-016-5082-2
Wu M, Wang Y, Wang Y, Zhang M, Luo Y et al (2017a) Paclitaxel-loaded and A10–3.2 aptamer-targeted poly (lactide-co-glycolic acid) nanobubbles for ultrasound imaging and therapy of prostate cancer. Int J Nanomed 12:5313–5330
Wu M, Zhao H, Guo L, Wang Y, Song J et al (2018a) Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10–3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer. Drug Deliv 25:226–240. https://doi.org/10.1080/10717544.2017.1422300
Wu P, Jia Y, Qu F, Sun Y, Wang P et al (2017b) Ultrasound-responsive polymeric micelles for sonoporation-assisted site-specific therapeutic action. ACS Appl Mater Interfaces 9(31):25706–25716. https://doi.org/10.1021/acsami.7b05469
Wu W, Luo L, Wang Y, Wu Q, Dai HB et al (2018b) Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications. Theranostics 8(11):3038–3058. https://doi.org/10.7150/thno.23459
Wu YP, Yang J, Gao HY, Shen Y, Jiang L et al (2018c) Folate-Conjugated Halloysite Nanotubes, an Efficient Drug Carrier, Deliver Doxorubicin for Targeted Therapy of Breast Cancer. ACS Appl Nano Mater 1:595–608. https://doi.org/10.1021/acsanm.7b00087
Xia L, Guo X, Liu T, Xu X, Jiang J et al (2019) Multimodality imaging of naturally active melanin nanoparticles targeting somatostatin receptor subtype 2 in human small-cell lung cancer. Nanoscale 11:14400–14409. https://doi.org/10.1039/c9nr043712
Xiao Y, Wang S, Zong Q, Yin Z (2018) Co-delivery of metformin and paclitaxel via folate-modified pH-sensitive micelles for enhanced anti-tumor efficacy. AAPS PharmSciTech 19(5):2395–2406. https://doi.org/10.1208/s12249018-1070-8
Xie P, Du P, Li J, Liu P (2019) Stimuli-responsive hybrid cluster bombs of PEGylated chitosan encapsulated DOX-loaded superparamagnetic nanoparticles enabling tumor-specific disassembly for on-demand drug delivery and enhanced MR imaging. Carbohydr Polym 205:377–384. https://doi.org/10.1016/j.carbpol.2018.10.076
Xie X, Fan Z, Li Y, Zhang Y, Yu F et al (2018) Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy. Int J Nanomed 13:1381–1398. https://doi.org/10.2147/IJN.S152312
Xing L, Shi Q, Zheng K, Shen M, Ma J et al (2016) Ultrasound-mediated microbubble destruction (UMMD) facilitates the delivery of CA19-9 targeted and paclitaxel loaded mpeg-plga-pll nanoparticles in pancreatic cancer. Theranostics 6(10):1573–1587. https://doi.org/10.7150/thno.15164
Xiong X, Xu Z, Huang H, Wang Y, Zhao J et al (2020) A NIR light triggered disintegratable nanoplatform for enhanced penetration and chemotherapy in deep tumor tissues. Biomaterials 245(119840):1–13. https://doi.org/10.1016/j.biomaterials.2020.119840
Xu C, Song R, Lu P, Chen JC, Zhou YQ et al (2018a) pH-triggered charge-reversal and redox-sensitive drug-release polymer micelles codeliver doxorubicin and triptolide for prostate tumor therapy. Int J Nanomed 13:7229–7249. https://doi.org/10.2147/IJN.S182197
Xu G, Chen Y, Shan R, Wu X, Chen L (2018b) Transferrin and tocopheryl-polyethylene glycol-succinate dual ligands decorated, cisplatin loaded nano-sized system for the treatment of lung cancer. Biomed Pharmacother 99:354–362. https://doi.org/10.1016/j.biopha.2018.01.062
Xu L, Yeudall WA, Yang H (2017a) Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery. Acta Biomater 57:251–326. https://doi.org/10.1016/j.actbio.2017.04.023
Xu W, Qian J, Hou G, Wang Y, Wang J et al (2019a) A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer. Acta Biomater 83:400–413. https://doi.org/10.1016/j.actbio.2018.11.026
Xu X, Wu J, Liu Y, Saw PE, Tao W et al (2017b) Multifunctional envelope-type siRNA delivery nanoparticle platform for prostate cancer therapy. ACS Nano 11:2618–2627. https://doi.org/10.1021/acsnano.6b07195
Xu X, Chong Y, Liu X, Fu H, Yu C et al (2019b) Multifunctional nanotheranostic gold nanocages for photoacoustic imaging guided radio/photodynamic/photothermal synergistic therapy. Acta Biomater 15(84):328–338. https://doi.org/10.1016/j.actbio.2018.11.043
Yameen B, Choi WI, Vilos C, Swami A, Shi J et al (2014) Insight into nanoparticle cellular uptake and intracellular Targeting. J Control Release 190:485–499. https://doi.org/10.1016/j.jconrel.2014.06.038
Yan R, Li K, Yuan D, Wang H, Zhang Y et al (2018) Downregulation of micro RNA-4295 enhances Cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1. Int J Oncol 53(6):2566–2578. https://doi.org/10.3892/ijo.2018.4595
Yan Y, Fu H, Wang J, Chen C, Wang Q et al (2019) A photo-stable and reversible pH-responsive nano-agent based on the NIR phenazine dye for photoacoustic imaging-guided photothermal therapy. Chem Commun 55:10940–10943. https://doi.org/10.1039/c9cc05624f
Yang C, Li Y, Du M, Chen Z (2019) Recent advances in ultrasound-triggered therapy. J Drug Target 27(1):33–50. https://doi.org/10.1080/1061186X.2018.1464012
Yang G, Xu L, Xu J, Zhang R, Song G et al (2018a) Smart nanoreactors for pH-responsive tumor homing, mitochondria-targeting, and enhanced photodynamic- immunotherapy of cancer. Nano Lett 18:2475–2484. https://doi.org/10.1021/acs.nanolett.8b00040
Yang L, Sajja HK, Cao Z, Qian W, Bender L et al (2014) uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection. Theranostics 4(1):106–118. https://doi.org/10.7150/thno.7409
Yang S, Wang Y, Ren Z, Chen M, Chen W et al (2018b) Stepwise pH/reduction-responsive polymeric conjugates for enhanced drug delivery to tumor. Mater Sci Eng C Mater Biol Appl 82:234–243. https://doi.org/10.1016/j.msec.2017.08.079
Yang X, Xue X, Luo Y, Lin TY, Zhang H et al (2017) Sub-100 nm, long tumor retention SN-38-loaded photonic micelles for tri-modal cancer therapy. J Control Release 261:297–306. https://doi.org/10.1016/j.jconrel.2017.07.014
Yao Q, Liu Y, Kou L, Tu Y, Tang X et al (2019) Tumor-targeted drug delivery and sensitization by MMP2-responsive polymeric micelles. Nanomedicine 19:71–80. https://doi.org/10.1016/j.nano.2019.03.012
Ye J, Yang Y, Dong W, Gao Y, Meng Y et al (2019) Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages. Int J Nanomed 14:3203–3220
Ye Z, Qian Q, Jin H, Qian Q (2018) Cancer vaccine: learning lessons from immune checkpoint inhibitors. J Cancer 9(2):263–268. https://doi.org/10.7150/jca.20059
Yeh C, Hsiao JK, Wang YP, Lan CH, Wu HC (2016) Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer. Biomaterials 99:1–15. https://doi.org/10.1016/j.biomaterials.2016.05.015
Yildirim A, Blum NT, Goodwin AP (2019) Colloids, nanoparticles, and materials for imaging, delivery, ablation, and theranostics by focused ultrasound (FUS). Thernostics 9(9):2572–2594. https://doi.org/10.7150/thno.32424
Yin T, Wang P, Li J, Wang Y, Zheng B et al (2014) Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes. Biomaterials 35:5932–5943. https://doi.org/10.1016/j.biomaterials.2014.03.072
Yoo J, Park C, Yi G, Lee D, Koo H (2019) Active targeting strategies using biological ligands for nanoparticle drug delivery systems. Cancers (basel) 11(5):640. https://doi.org/10.3390/cancers11050640
Yordanova A, Eppard E, Kürpig S, Bundschuh RA, Schönberger S et al (2017) Theranostics in nuclear medicine practice. Onco Targets Ther 10:4821–4828. https://doi.org/10.2147/OTT.S140671
Yoshizaki Y, Yuba E, Sakaguchi N, Koiwai K, Harada A et al (2017) pH-sensitive polymer-modified liposome-based immunity-inducing system: effects of inclusion of cationic lipid and CpG-DNA. Biomaterials 141:272–283. https://doi.org/10.1016/j.biomaterials.2017.07.001
Yu SS, Lau CM, Barham WJ, Onishko HM, Nelson CM et al (2013) Macrophage-specific RNAi targeting via ‘Click’, annosylated polymeric micelles. Mol Pharm 10(3):975–987. https://doi.org/10.1021/mp300434e
Yu X, Xue L, Zhao J, Zhao S, Wu D, Liu HY (2021) Non-cationic RGD-containing protein nanocarrier for tumor-targeted siRNA delivery. Pharmaceutics 13(2182):1–18. https://doi.org/10.3390/pharmaceutics13122182
Yuba E, Takashima M, Hayashi T, Kokuryo D, Aoki I (2021) Multifunctional traceable liposomes with temperature-triggered drug release and neovasculature-targeting properties for improved cancer chemotherapy. Mol Pharmaceutics 18(9):3342–3351. https://doi.org/10.1021/acs.molpharmaceut.1c00263
Yuba E, Uesugi S, Miyazaki M, Kado Y, Harada A et al (2017a) Development of pH-sensitive dextran derivatives with strong adjuvant function and their application to antigen delivery. Membranes 7:41. https://doi.org/10.3390/membranes7030041
Yuba E, Yamaguchi A, Yoshizaki Y, Harada A, Kono K (2017b) Bioactive polysaccharide-based pH-sensitive polymers for cytoplasmic delivery of antigen and activation of antigen-specific immunity. Biomaterials 120:32–45. https://doi.org/10.1016/j.biomaterials.2016.12.021
Zang X, Zhao X, Hu M, Qiao M, Deng Y et al (2017) Nanoparticles for tumor immunotherapy. Eur J Pharm Biopharm 115:243–256. https://doi.org/10.1016/j.ejpb.2017.03.013
Zavaleta C, Ho D, Chung EJ (2018) Theranostic nanoparticles for tracking and monitoring disease state. SLAS Technol 23(3):281–293
Zhang A, Pan S, Zhang Y, Chang J, Cheng J, at al. (2019a) Carbon-gold hybrid nanoprobes for real-time imaging, photothermal/photodynamic and nanozyme oxidative therapy. Theranostics 9(12):3443–3458. https://doi.org/10.7150/thno.33266
Zhang B, Shen S, Liao Z, Shi W, Wang Y et al (2014a) Targeting fibronectins of glioma extracellular matrix by CLT1 peptide conjugated nanoparticles. Biomaterials 35:4088–4098. https://doi.org/10.1016/j.biomaterials.2014.01.046
Zhang C, Yu X, Gao L, Zhao Y, Lai J et al (2017a) Noninvasive imaging of CD206-positive M2 macrophages as an early biomarker for post-chemotherapy tumor relapse and lymph node metastasis. Theranostics 7(17):4276–4288. https://doi.org/10.7150/thno.20999
Zhang D, Ye Z, Wei L, Luo H, Xiao L (2019b) Cell membrane-coated porphyrin metal−organic frameworks for cancer cell targeting and O2-evolving photodynamic therapy. ACS Appl MaterInterfaces 11(43):39594–39602. https://doi.org/10.1021/acsami.9b14084
Zhang K, Li J, Xin X, Du X, Zhao D et al (1990) Dual targeting of cancer cells and MMPs with self-assembly hybrid nanoparticles for combination therapy in combating cancer. Pharmaceutics 13:1–22
Zhang L, Yi H, Song J, Huang J, Yang K et al (2019c) Mitochondria-targeted and ultrasound-activated nanodroplets for enhanced deep-penetration sonodynamic cancer therapy. ACS Appl Mater Interfaces 11:9355–9366. https://doi.org/10.1021/acsami.8b21968
Zhang P, An K, Duan X, Xu H, Li F, Xu F (2018a) Recent advances in siRNA delivery for cancer therapy using smart nanocarriers. Drug Discov Today 23(4):900–911. https://doi.org/10.1016/j.drudis.2018.01.042
Zhang Q, Zhang Y, Li K, Wang H, Li H et al (2015) A novel strategy to improve the therapeutic efficacy of gemcitabine for non-small cell lung cancer by the tumor-penetrating peptide Irgd. PLoS ONE 10(6):e0129865. https://doi.org/10.1371/journal.pone.0129865
Zhang R, Yang J, Sima M, Zhou Y, Kopecek J (2014b) Sequential combination therapy of ovarian cancer with degradable N-(2-hydroxypropyl) methacrylamide copolymer paclitaxel and gemcitabine conjugates. Proc Natl Acad Sci USA 111(33):12181–12186
Zhang T, Jiang Z, Xve T, Sun S, Li J et al (2019d) One-pot synthesis of hollow PDA@DOX nanoparticles for ultrasound imaging and chemo-thermal therapy in breast cancer. Nanoscale 11:21759–21769. https://doi.org/10.1039/c9nr05671h
Zhang X, Hong K, Sun Q, Zhu Y, Du J (2021) Bioreducible, arginine-rich polydisulfide-based siRNA nanocomplexes with excellent tumor penetration for efficient gene silencing. Biomater Sci 9(15):5275–5292. https://doi.org/10.1039/d1bm00643f
Zhang X, Zhang H, Yin L, Hu R, Qiu T et al (2016) A pH-Sensitive nanosystem based on carboxymethyl chitosan for tumor-targeted delivery of daunorubicin. J Biomed Nanotechnol 12:1688–1698. https://doi.org/10.1166/jbn.2016.2278
Zhang Y, Leonard M, Shu Y, Yang Y, Shu D et al (2017b) Overcoming tamoxifen resistance of human breast cancer by targeted gene silencing using multifunctional pRNA nanoparticles. ACS Nano 11:335–346. https://doi.org/10.1021/acsnano.6b05910
Zhang Z, Qian H, Huang J, Sha H, Zhang H et al (2018b) Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment. Int J Nanomed 13:4961–4975. https://doi.org/10.2147/IJN.S170148
Zhao H, Li Y, Wei D, Luo H (2018a) The application of nanoparticle-based drug delivery systems in checkpoint blockade cancer immunotherapy. J Immunol Res 2018:3673295. https://doi.org/10.1155/2018/3673295
Zhao L, Wen S, Zhu M, Li D, Xing Y et al (2018b) 99mTc-labelled multifunctional polyethylenimine-entrapped gold nanoparticles for dual mode SPECT and CT imaging, artificial cells. Nanomed Biotechnol 46(1):488–498. https://doi.org/10.1080/21691401.2018.1430696
Zhao L, Li Y, Zhu J, Sun N, Song N et al (2019a) Chlorotoxin peptide-functionalized polyethylenimine-entrapped gold nanoparticles for glioma SPECT/CT imaging and radionuclide therapy. J Nanobiotechnol 17(30):1–13. https://doi.org/10.1186/s12951-019-0462-6
Zhao Z, Xu K, Fu C, Liu H, Lei M et al (2019b) Interfacial engineered gadolinium oxide nanoparticles for magnetic resonance imaging guided microenvironment mediated synergetic chemodynamic/photothermal therapy. Biomaterials 219:119379. https://doi.org/10.1016/j.biomaterials.2019.119379
Zhao Z, Xu K, Fu C, Liu H, Lei M et al (2019c) nterfacial engineered gadolinium oxide nanoparticles for magnetic resonance imaging guided microenvironment-mediated synergetic chemodynamic/photothermal therapy. Biomaterials 219:119379. https://doi.org/10.1016/j.biomaterials.2019.119379
Zhao H, Wu M, Zhu L, Tian Y, Wu M et al (2018) Cell-penetrating peptide-modified targeted drug-loaded phase-transformation lipid nanoparticles combined with low-intensity focused ultrasound for precision theranostics against hepatocellular carcinoma. Theranostics 8(7):1892. https://doi.org/10.7150/thno.22386
Zhong S, Chen C, Yang G, Zhu Y, Cao H et al (2019) Acid-triggered nanoexpansion polymeric micelles for enhanced photodynamic therapy. ACS Appl Mater Interfaces 11(37):33697–33705. https://doi.org/10.1021/acsami.9b12620
Zhou D, Li C, He M, Ma M, Li P et al (2016) Folate-targeted perfluorohexane nanoparticles carrying bismuth sulfide for use in US/CT dual mode imaging and synergistic high-intensity focused ultrasound ablation of cervical cancer. J Mater Chem B 4:4164–4181. https://doi.org/10.1039/c6tb00261g
Zhou J, Tiemann K, Chomchan P, Alluin J, Swiderski P et al (2013) Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells. Nucleic Acids Res 41(7):4266–4283. https://doi.org/10.1093/nar/gkt125
Zhou K, Nguyen LH, Miller JB, Yan Y, Kos P et al (2016b) Modular degradable dendrimers enable small RNAs to extend survival in an aggressive liver cancer model. Proc Natl Acad Sci 113:520–525. https://doi.org/10.1073/pnas.1520756113
Zhu M, Ding X, Zhao R, Liu X, Shen H et al (2018a) Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma. J Control Release 272:72–82. https://doi.org/10.1016/j.jconrel.2018.01.004
Zhu Y, Jiang Y, Meng F, Deng C, Cheng R et al (2018b) Highly efficacious and specific antiglioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell penetrating peptides. J Control Release 278:1–8. https://doi.org/10.1016/j.jconrel.2018.03.025
Zielonka J, Sikora A, Hardy M, Ouari O, Vivar JVB et al (2017) Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications. Chem Rev 117(15):10043–10120. https://doi.org/10.1021/acs.chemrev.7b00042
Acknowledgements
The authors would like to acknowledge the Library facility of The Hebrew University of Jerusalem, Israel, and NEIST, Jorhat, India for providing access to literature review.
Funding
None.
Author information
Authors and Affiliations
Contributions
BPS: 35% (Lead author and contributed the majority of literature review and compiling of the manuscript), RB: 25% (Co-Corresponding author contributed significantly to literature review and restructuring of the manuscript). JLH: 15% (Supporting author contributed to technical writing and language polishing of the manuscript). DL: 10% (Supporting author by helping with the corrections of Typographical errors and editing). NB: 15% (Supporting author contributed by compiling all the references and proofreading and cross-checks).
Corresponding author
Ethics declarations
Conflict of interest
All authors (B.P. Sahu, R. Baishya, J.L.H. Boruah, D. Laloo, and N. Biswas) declare no conflict of Interest.
Statement of human and animal rights
This article does not contain any studies with human and animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sahu, B.P., Baishya, R., Hatiboruah, J.L. et al. A comprehensive review on different approaches for tumor targeting using nanocarriers and recent developments with special focus on multifunctional approaches. J. Pharm. Investig. 52, 539–585 (2022). https://doi.org/10.1007/s40005-022-00583-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40005-022-00583-x